Careers

Neurodegeneration Biomarkers CSF

Affiches Jun 9, 2017

Neurosciences

Spectrométrie de masse

June 9, 2017

Pascal Croteau¹, Fiona McAllister¹, Laura McIntosh¹, Laetitia Cortes¹, Michael Schirm¹, Howard Schulman¹, Jane Paulsen², Daniel Chelsky¹. ¹Caprion Biosciences Inc, Montreal, Canada; ²The University of Iowa, Iowa City, IA.

Multiplexed Mass Spectrometry Assay Identifies Neurodegeneration Biomarkers in CSF, CNS Summit 2017

Affiches

Apr 14, 2026

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS

Affiches

Mar 3, 2026

Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

Affiches

Mar 3, 2026

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Neurodegeneration Biomarkers CSF

Featured Resources

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS

Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

One global CRO for your whole therapeutic development journey